Lunai Bioworks (LNAI) Non Operating Income (2014 - 2026)
Lunai Bioworks (LNAI) recorded quarterly Non Operating Income of -$1.1 million in Q1 2026, down 4865.24% quarter-over-quarter from $24010.0 in Q4 2025, and down 126.29% on a YoY basis from $4.4 million in Q1 2025.
Lunai Bioworks (LNAI) Non Operating Income (2014 - 2026) Analysis & Trends
Lunai Bioworks' Non Operating Income history runs 13 years deep, the most recent figure standing at -$1.1 million for Q1 2026.
- In Q1 2026, Non Operating Income fell 126.29% year-over-year to -$1.1 million; the TTM figure through Mar 2026 stood at $5.2 million (down 57.24% YoY), while the FY2025 annual figure was $11.0 million, up 261.47% from the prior year.
- Non Operating Income was -$1.1 million for Q1 2026 at Lunai Bioworks, down from $24010.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $9.1 million in Q3 2024 to a low of -$7.6 million in Q1 2024.
- Historically, Non Operating Income has averaged $815137.5 across 5 years, with a median of -$259046.0 in 2023.
- Biggest YoY gain for Non Operating Income was 3237.19% in 2024; the steepest drop was 2772.93% in 2024.
- A 5-year view of Non Operating Income shows it stood at -$89882.0 in 2022, then sank by 188.21% to -$259046.0 in 2023, then plunged by 944.63% to -$2.7 million in 2024, then jumped by 100.89% to $24010.0 in 2025, then plunged by 4865.24% to -$1.1 million in 2026.
- The last three Non Operating Income figures came in at -$1.1 million (Q1 2026), $24010.0 (Q4 2025), and $6.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 | -1.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.14 Mn |
| Dec 31, 2025 | 24,010.00 |
| Sep 30, 2025 | 6.13 Mn |
| Jun 30, 2025 | 186,405.00 |
| Mar 31, 2025 | 4.35 Mn |
| Dec 31, 2024 | -2.71 Mn |
| Sep 30, 2024 | 9.13 Mn |
| Jun 30, 2024 | 1.37 Mn |
| Mar 31, 2024 | -7.61 Mn |
| Dec 31, 2023 | -259,046.00 |
| Sep 30, 2023 | -290,914.00 |
| Jun 30, 2023 | -263,279.00 |
| Mar 31, 2023 | -264,860.00 |
| Dec 31, 2022 | -89,882.00 |
| Sep 30, 2022 | -509,144.00 |
| Jun 30, 2022 | 7.97 Mn |
| Mar 31, 2022 | -2.17 Mn |
| Dec 31, 2021 | -252,150.00 |
| Sep 30, 2021 | -2.91 Mn |
| Jun 30, 2021 | -3.18 Mn |